Medicine Information

Generating Pharmaceutical Sales before Marketing Authorization


When a patient has a serious illness and there is no approved drug available, the physician may want to try one which has not been authorized for marketing by national health authorities but has shown promise in clinical trials. European Named Patient Programs, like US compassionate use programs, offer physicians access to pharmaceuticals which have not yet been licensed. However, there is one important difference: in Europe an unlicensed drug can be reimbursed. This presents drug-makers with an opportunity to generate revenues while development is still in-progress.

Significant Revenues Are Possible

The additional revenues can be considerable. For example, Pharmion, a US based company focusing on Oncology and Hematology reported dramatic increases in its Thalidomide sales from $1.9 million in 2Q '03 to $15.3 million in 2Q '04, primarily due to named patient sales in Europe for Multiple Myeloma. Thalidomide sales accounted for approximately 75% of Pharmion's total revenues for the first half of 2004, according to company sources, and were generated while the product awaits marketing approval for this indication. Before receiving European Marketing Approval, Shire's Argylin® for essential thrombocythaemia generated about 5% of its total sales from its European named patient program.

Though thalidomide and Agrylin were licensed in the USA for some indications, pharmaceutical companies do set-up named patient programs and receive full reimbursement for drugs that are not licensed for any indication in any market. Examples include: Insmed's SomatoKine® authorized for named patient use for Primary Lateral Sclerosis, Growth Hormone Insensitivity Syndrome (GHIS) and Severe Insulin Resistance and Protherics' ViperaTAb? authorized for named patient use for adder snake bites.

Other Benefits of Named Patient Programs

A named patient program can speed uptake after official launch. Physicians, who have had experience before launch, via clinical trials or named patient programs, often become early adopters and references for other physicians once the drug is freely circulating.

Named patient programs, like US compassionate use programs, can increase good-will toward the company because they simplify the process of gaining access for patients in critical need. Smaller companies often can not afford the administrative time and costs of shipping drugs around the world before launch. This can lead to frustration and resentment towards a company that many physicians will remember long after a drug is officially on the market. Creating a formal channel eliminates the unfortunate need of denying requests and risking ill-will later.

A named patient program should be considered an important part of a pre-launch program. It increases awareness to a pharmaceutical's existence, creates excitement, generates good-will and speeds penetration of the product after launch.

Frequent Communication is Necessary

If one of the objectives is to generate revenues, setting up a named patient program is just the beginning. In order to achieve success, physicians need to be aware of the product and what they need to do to get it. Typical methods of informing physicians, such as sales rep visits and ads, may not be appropriate because a license is necessary to market a drug. While physicians are used to simply writing a prescription and being done with it, named patient programs require paper-work that some find tedious. Therefore the company needs to create an appropriate communication plan and work closely with the targeted medical community to keep them informed and simplify the process.

Issues to Consider

You have decided to make a named patient program part of your pre-marketing plan, what now?

? Administration: Do you "go it alone" or work with a company that is experienced at administering named patient programs?

There are several experienced organizations that can assist your company by gaining approval, setting-up the program, doing administration and taking care of physical distribution. If your organization is well resourced and has a pipe-line of products that will require named patient programs, it might be worthwhile acquiring the expertise internally. However, if you have few appropriate products or a stream-lined organization, it is probably best to consider outsourcing.

? Communication: You've set up the program, how do you optimize it?

If you do not have an experienced European marketing group, an organization that is familiar in sales and marketing of pharmaceuticals in Europe can help you to maximize participation in the named patient program. A communication plan, if properly developed and implemented can increase product awareness, but communication concerning an unlicensed product must be done appropriately. This plan should ensure that your entire target group:

? Is fully aware of the product AND the program

? Knows what needs to be done to take advantage of the program

? Has an advocate available to guide them through the process

The Author, Dr Gene Emmer, is President of Med Services Europe B.V., a European-based consultancy focused on Sales, Marketing and Business Development of Pharmaceutical, Diagnostic and Medical Products. http://www.MedServicesEurope.com +31648566707


MORE RESOURCES:

Snohomish Times

Thousands of Doctors May Quit Medicine Over Obamacare
Snohomish Times
In the survey, 29.2 percent of practicing physicians said they would quit practicing medicine or retire early if faced with the healthcare reform. ...
What's health care without doctors?Boston Herald
EXCLUSIVE: Contradicting right-wing paper, NE Journal of Medicine says its ...Media Matters for America (blog)
Will Health Reform Cause Doctors To Flee?Forbes (blog)
New Haven Register (subscription) -Benzinga -Hot Air (blog)
all 57 news articles »


The Star-Ledger - NJ.com (blog)

Tough medicine: Gov. Chris Christie's proposed cap on public worker costs is a ...
The Star-Ledger - NJ.com (blog)
By Star-Ledger Editorial Board/The Star-Led... In the long run, the most important move Gov. Chris Christie has made to shrink government is not his cuts to ...
Tough medicine Christie stumps in Hudson County for proposed state cutsThe Hudson Reporter
New Jersey: A Blue State Deep in Debt Rethinks What's ImportantNew York Times

all 22 news articles »


HL:Mathews makes 20 saves as Kootenay Ice shut out Medicine Hat Tigers 4-0@
USA Today
LOS ANGELES (AP) — CRANBROOK, BC -- Kootenay Ice goaltender Todd Mathews stopped 20 shots in a 4-0 win over the Medicine Hat Tigers in Western Hockey League ...
HL:King and Sylvester lead the way as Kootenay Ice trounce Medicine Hat 6-2@USA Today

all 17 news articles »



David Horowitz's NewsReal Blog (blog)

Kansas City's Iron Bishops: Fight For Unborn, Reject Socialized Medicine
David Horowitz's NewsReal Blog (blog)
American Catholics agonizing about today's vote on ObamaCare will have mixed feelings about the United States Catholic Conference of ...

and more »


Preventive Medicine: Buying Health Stocks Before Overhaul
Wall Street Journal
The health-care bill has created angst in Congress, but some mutual-fund managers have been buying stocks they believe were pinched by the ...



Millennials in medicine take healthier approach to work hours
Washington Post
The veterans expressed frustration that the new generation didn't want to learn medicine the same way they did in the 1970s and 1980s. ...



How Could Flawless Diamonds Change Future of Medicine?
ABC News
The diamonds adorning the fingers of married women everywhere might be labeled as flawless, but compared to the gems at Argonne National ...

and more »


Analysis: Mo. medicine law still not in effect
CNBC
JEFFERSON CITY, Mo. - A 2008 Missouri law expanding the ability of thousands of specially trained nurses to write prescriptions still has not been ...

and more »


PGI happy with results of pilot study on Vaid's asthma medicine
Indian Express
The institute conducted the study on the medicine on asthmatic children who were going off-therapy. The Vaid's formulation had earlier been extensively ...


Google News

home | site map
© 2006